6733 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
BioGend Therapeutics Co., Ltd. engages in the development of medical equipment to restore bone and joint functions. Its products include bioactive bone graft material, biphasic cartilage repair implant and biological aggregates. The company was founded on July 7, 2016 and is headquartered in Taipei, Taiwan.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
6733 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company